Stanhep 25 Iniekcja heparyny sodowej
✅ Prevents blood clots
✅ Reduces clotting risk
✅ Treats thrombosis
✅ Minimizes embolism risk
✅ Improves blood flow
Stanhep 25 contains Heparin Sodium.
✓ Zweryfikowany medycznie przez Morgan Ellis — Badacz farmaceutyczny · 8 lat doświadczenia · Ostatnia weryfikacja: maj 2026
⚡ Quick Answer — What is Stanhep 25?
Stanhep 25 is 25,000 IU per 5 mL vial unfractionated heparin sodium injection from a WHO-GMP certified manufacturer — an indirect parenteral anticoagulant administered by IV infusion or subcutaneous injection in hospital. Heparin works by potentiating antithrombin, which then inactivates thrombin (IIa) and factor Xa. Onset is immediate (IV) and the half-life is short (60-90 min) — making it the anticoagulant of choice when rapid onset, rapid offset, and protamine reversal matter (acute coronary syndrome, peri-operative bridging, dialysis, renal failure where LMWH accumulates). Dose is weight-based and titrated to aPTT 1.5-2.5x baseline or anti-Xa 0.3-0.7 IU/mL. The major life-threatening complication is heparin-induced thrombocytopenia (HIT), an immune reaction usually appearing on day 5-10. Reversal: protamine sulfate. This is a hospital-only product administered under medical supervision — not for self-injection.
📦 Każde zamówienie jest objęte naszą Reshipment Assurance Policy — jeśli Twoja przesyłka nie dotrze w ciągu 20 dni roboczych, wysyłamy ją ponownie.
Dlaczego warto zamawiać z MedsBase
Nasze leki generyczne pochodzą od producentów posiadających certyfikat WHO-GMP i są wysyłane na cały świat w dyskretnym, zwykłym opakowaniu — bez nazwy leku na zewnątrz przesyłki. Płatności kartami są kierowane przez regulowanego procesora (opis wyciągu zawiera nazwę regulowanego procesora płatności — nigdy “MedsBase” ani żadnej nazwy leku). Akceptujemy również kryptowaluty i przelewy bankowe SEPA. Każde zamówienie jest objęte naszą Reshipment Assurance Policy.
What Is Stanhep 25?
Stanhep 25 is unfractionated heparin (UFH) sodium 25,000 IU per 5 mL vial injection from a WHO-GMP certified manufacturer, supplied as 1-10 vials. UFH is the prototype parenteral anticoagulant in clinical use since the 1930s. Despite the rise of LMWH and DOACs it retains key roles where rapid onset, rapid offset, and protamine reversibility matter.
How Heparin Works
Heparin binds antithrombin III via its pentasaccharide sequence and accelerates antithrombin’s inhibition of thrombin (factor IIa) and factor Xa about 1,000-fold. UFH inhibits IIa and Xa roughly equally; LMWHs preferentially inhibit Xa. Onset is immediate when given IV; subcutaneous onset is 20-30 min. Plasma half-life is 60-90 min, dose-dependent, allowing rapid offset.
Zatwierdzone zastosowania
- Acute coronary syndrome (NSTEMI / unstable angina, STEMI) — with antiplatelets and PCI
- Acute venous thromboembolism (DVT, PE) — especially when LMWH is unsuitable (severe renal failure, anticipated procedures)
- Peri-operative bridging in patients on long-term anticoagulation undergoing surgery
- Cardiopulmonary bypass and ECMO circuits
- Continuous renal replacement therapy (CRRT) and haemodialysis — circuit anticoagulation
- Catheter and line patency — low-dose flush (separate, lower-strength preparations)
- Atrial fibrillation cardioversion bridging
Dawkowanie i monitorowanie
| Wskazanie | Loading dose | Dawka podtrzymująca | Docelowa |
|---|---|---|---|
| Acute VTE (treatment) | 80 IU/kg IV bolus | 18 IU/kg/h IV infusion | aPTT 1.5–2.5× baseline |
| ACS | 60 IU/kg (max 4,000 IU) | 12 IU/kg/h (max 1,000 IU/h) | aPTT 50–70 sec |
| SC prophylaxis | — | 5,000 IU SC q8–12h | No routine monitoring |
| Cardiopulmonary bypass | 300–400 IU/kg IV | Re-dose to maintain ACT | ACT >480 sec |
Monitor aPTT or anti-Xa (0.3–0.7 IU/mL) every 6 hours after initiation or dose change, then daily once stable. Check baseline FBC, PT, aPTT, fibrinogen, renal and hepatic function.
Heparin-Induced Thrombocytopenia (HIT)
Działania niepożądane
- Bleeding (major bleeding rate ~5% on therapeutic IV heparin)
- Heparin-induced thrombocytopenia (HIT) — type II, immune-mediated, life-threatening
- Mild benign drop in platelets (HIT type I, non-immune, transient)
- Hyperkalaemia (aldosterone suppression, especially in diabetes and renal failure)
- Osteoporosis with prolonged use >3 months
- Injection-site bruising / haematoma (SC route)
- Hypersensitivity reactions, rarely anaphylaxis
- LFT elevation
Przeciwwskazania
- Active major bleeding
- Known HIT or history of HIT (use a non-heparin anticoagulant)
- Severe thrombocytopenia (platelets <50×109/L)
- Severe uncontrolled hypertension
- Recent intracranial, ophthalmic, or major surgery with bleeding risk
- Peptic ulcer with active bleeding, oesophageal varices
- Hypersensitivity to heparin or pork products
Interakcje lekowe
- Other anticoagulants / antiplatelets (warfarin, DOACs, aspirin, clopidogrel, NSAIDs, fibrinolytics) — additive bleeding risk; combine only when clinically indicated under specialist supervision.
- Glyceryl trinitrate IV infusion — may reduce heparin effect; aPTT monitoring as usual.
- SSRIs/SNRIs — modest additive bleeding risk.
Reversal: Protamine Sulfate
For major bleeding or pre-emergency reversal, protamine sulfate neutralises heparin: 1 mg protamine per 100 IU heparin given in the previous 2-3 hours, slow IV (max 50 mg over 10 min) to avoid hypotension and anaphylactoid reactions. Maximum single dose 50 mg; recheck aPTT after 5-15 min. Higher risk of protamine reaction in patients with prior NPH insulin exposure, fish allergy, or vasectomy.
Pregnancy and Breastfeeding
Heparin and LMWH do not cross the placenta and are the anticoagulants of choice in pregnancy. LMWH is preferred for outpatient use. Breastfeeding: heparin is not excreted in breast milk (large molecule) — safe.
Przechowywanie
Store Stanhep 25 below 25°C, do not freeze. Once a vial is broached, follow institutional sterility protocols. Keep out of reach of children.
Najczęściej zadawane pytania
Can I use Stanhep 25 at home?
No. Stanhep 25 is a high-strength multi-dose vial (25,000 IU/5 mL) intended for hospital IV infusion or in-patient SC dosing under aPTT or anti-Xa monitoring. At-home anticoagulation is normally LMWH (enoxaparin, dalteparin) or a DOAC.
What is the difference between heparin and LMWH?
Unfractionated heparin (UFH) is a heterogeneous mixture inhibiting IIa and Xa equally, with a short half-life and aPTT monitoring. LMWHs (enoxaparin, dalteparin) are smaller, preferentially inhibit Xa, have a longer predictable half-life, can be given subcutaneously without monitoring in most patients, and are first-line outpatient choice. UFH is preferred when rapid offset, severe renal failure, or protamine reversibility matter.
What is HIT and how is it treated?
Heparin-induced thrombocytopenia is an immune reaction (anti-PF4/heparin antibodies) usually on day 5-10 of heparin, causing a paradoxical pro-thrombotic state. Stop all heparin (including flushes), avoid warfarin until platelets recover, and start a non-heparin anticoagulant (argatroban, danaparoid, fondaparinux, or bivalirudin). Confirm with anti-PF4 ELISA and serotonin release assay.
How is heparin reversed?
Protamine sulfate. 1 mg per 100 IU heparin given in the previous 2-3 hours, slow IV. Maximum single dose 50 mg. Recheck aPTT 5-15 min after.
Why monitor aPTT?
UFH dose response is unpredictable because it binds plasma proteins variably. The aPTT reflects intrinsic-pathway anticoagulation; target is 1.5-2.5× baseline (typically 50-70 sec) for therapeutic anticoagulation. Anti-Xa (0.3-0.7 IU/mL) is the alternative target where available.
Is heparin safe in pregnancy?
Yes — heparin (and LMWH) do not cross the placenta and are the anticoagulants of choice when anticoagulation is needed in pregnancy. Warfarin is teratogenic; DOACs lack pregnancy data.
Can heparin cause hyperkalaemia?
Yes — especially in diabetes and renal failure, due to aldosterone suppression. Check potassium at baseline and during prolonged therapy.
What if a child accidentally swallows a heparin vial?
Heparin is not absorbed orally — oral ingestion is essentially harmless from an anticoagulation standpoint. Take the child to A&E for assessment regardless. Parenteral exposure is a different matter.
How is heparin used during dialysis?
Continuous infusion or bolus dosing into the dialysis circuit prevents clotting in the extracorporeal system. Doses are unit-protocol-driven; ACT or aPTT may be monitored during the run.
Where can I buy Stanhep 25 online?
You can buy Stanhep 25 (25,000 IU per 5 mL vial, 1-10 vials) from MedsBase with discreet packaging and worldwide shipping. This is a hospital-use parenteral product — it must be administered by trained clinicians.
Other Anti-Coagulants and Antiplatelets
- Warf — Warfarin 1/2/5 mg
- Waf-5 — Warfarin 5 mg
- Uniwarfin — Warfarin 5 mg (Unichem)
- Xarelto 20 — Rivaroxaban 20 mg
- Eliquis — Apixaban 2.5/5 mg
- Plavix — Clopidogrel 75 mg (Sanofi)
- Browse all Anti-Coagulants & Antiplatelets
Powiązane alternatywy
Inne produkty w Zdrowie ogólne które klienci również przeglądają:
More options in Anti Coagulants
Ranking według liczby ostatnich zamówień MedsBase — co wybierają inni klienci w tej kategorii.
| Moc | 25.000 IU/5ml |
|---|---|
| Ilość | 1 Vial/s, 2 Vial/s, 3 Vial/s, 10 Vial/s |
Stanhep 25 Iniekcja heparyny sodowej
Pytania i odpowiedzi
Stanhep 25 Iniekcja heparyny sodowej
Produkty powiązane
Opinie
Nie ma jeszcze opinii